Global Microneedle Drug Delivery Systems Industry Overview | By Product (Hollow Microneedle Technology, Solid Microneedle Technology, Dissolving Microneedles Technology), and Application (Fruits and vegetables, Meat products, Juices and other beverages, Seafood, Biotechnology, Others) - Global Market Opportunity and Current Growth Analysis 2019-2025

Global Microneedle Drug Delivery Systems Industry was valued at USD$ Million in the year 2019. Global Microneedle Drug Delivery Systems Industry is further estimated to grow at a CAGR of xx% from 2019 to reach USD$ Million by the year 2025. Microneedle drug delivery systems usually include hollow microneedle and solid microneedle technology, offer patient-friendly delivery solutions for vaccines or difficult-to-deliver biologics for particularly needle-phobic patients.
Intradermal drug delivery is increasingly recognized as a potential solution to many of the challenges faced by new and existing medicines. Intradermal dosing provides the opportunity to more effectively administer agents such as small molecules, biologics, and vaccines, allowing for improved bioavailability. Nonetheless, the widespread use of this route of administration continues to be limited by technical challenges in the performing of intradermal injections, which requires specialized training and has poor reproducibility.
Microneedles are a rapidly growing technology developed to solve issues surrounding intradermal drug administration. While many microneedle platforms have been developed over nearly 2 decades, the issues and concerns remain largely the same.
Major market players in Microneedle Drug Delivery Systems Industry are Pfizer, F. Hoffman La Roche, Johnson & Johnson, Novartis, Bayer, 3M, Vetter Pharma International GmbH, nanoBioSciences LLC, NanoPass, Microdermics Inc, Zosano Pharma Corporation, Micropoint Technologies Pte Ltd, BuBclean, MyLife Technologies, Innoture Medical Technology Limited, Phillips Plastic Corporation, Corium International Inc., Stemedica Cell Technologies Inc.

Microneedle Drug Delivery Systems Industry, Segmentation:
Microneedle Drug Delivery Systems Industry Overview, By Product
• Hollow Microneedle Technology
• Solid Microneedle Technology
• Dissolving Microneedles Technology

Microneedle Drug Delivery Systems Industry Overview, By Application
• Drug Delivery
• Vaccine Delivery
• Other

Microneedle Drug Delivery Systems Industry Overview, By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.